Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Item

http://www.wikidata.org/entity/Q34195822

Q34195822

about

Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome Heart Failure: Diagnosis, Management and Utilization MicroRNA-regulated viral vectors for gene therapy Cardiomyopathy in becker muscular dystrophy: Overview Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies Repolarization Heterogeneity: Beyond the QT Interval Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation Prospects for gene transfer for clinical heart failure 'Ryanopathy': causes and manifestations of RyR2 dysfunction in heart failure Gene therapy on the move Keep your heart in shape: molecular chaperone networks for treating heart disease Cardiovascular gene therapy for myocardial infarction Heart failure with preserved ejection fraction Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies Targets for therapy in sarcomeric cardiomyopathies Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability.Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure Light-based Approaches to Cardiac Arrhythmia Research: From Basic Science to Translational Applications The fibrosis-cell death axis in heart failure "Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors Heart failure: advanced development in genetics and epigenetics Adeno-associated virus-mediated gene therapy in cardiovascular disease Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension S100A1 in human heart failure: lack of recovery following left ventricular assist device support Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice Targeting S100A1 in heart failure Molecular targets in heart failure gene therapy: current controversies and translational perspectives AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction Heart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodeling SUMO1-dependent modulation of SERCA2a in heart failure.Small and large animal models in cardiac contraction research: advantages and disadvantages SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway The effect of injection speed and serial injection on propidium iodide entry into cultured HeLa and primary neonatal fibroblast cells using lance array nanoinjection.Post-translational Modifications in Heart Failure: Small Changes, Big Impact Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure.

P2860

Q24337593-F0D4AC2D-0111-4008-948C-36B787065EF1 Q26745543-EA8D92B3-5CA5-4338-9F68-F440E7911C89 Q26745822-56A49042-2D2B-43C6-86BA-156A6BF74B89 Q26746151-B12BA8D9-32D6-497D-A67A-E9577625F0C9 Q26746907-4DE9F0E7-65A2-4A58-B6AA-645D92976F7E Q26748826-0E707A9D-5077-4D3B-B941-8CBFB26380A3 Q26753845-86343BFB-904D-4CC6-8FF4-D682C9FE36D4 Q26786817-5ED25452-7708-4DD5-BF08-8D7281191F7B Q26799437-C1568704-E0EF-45D8-9F77-E299971C6CB3 Q26830145-07425367-2E8A-4CDA-B5CE-7BB587A09798 Q26865421-FF59B198-F1B8-4F9A-89F2-C77B66E57A2A Q27007012-3FFE6BDF-1884-4D58-AAA3-B6D79FF84797 Q27010429-39DE1CF7-7A7F-48BD-A041-A8CF510B4B74 Q27014770-B210E868-4695-4318-8659-6AF93251FDCC Q27024008-43ED3CF6-C201-4098-B204-30C8149DCBE4 Q27024879-F924B76E-5845-4BBE-9373-1A3EB3B35C1B Q27026716-93395EA9-91C2-4E12-9193-1CB49701AF6C Q27027023-B3451315-A094-4822-AEC5-E21006DF341F Q27304840-8BE530C4-3DC9-4EAC-8480-2ACFAC06C0D2 Q27318604-643F518E-926B-4DFD-8BE2-EBA9AF7CF155 Q28075299-CBF5D012-A425-43FF-B9EA-4B2DC6222053 Q28076570-56627AF1-47E7-4E62-AFFD-C21DC9CC4110 Q28078766-CDAC011C-A890-4790-8A18-FE7C3386663D Q28080771-86FE1A58-C5D5-4732-BCDD-1BD1CE276CCA Q28081681-66118069-642B-44C3-AD62-2E2BA83E08C7 Q28085007-26A4AE52-E870-4943-B25F-561FC2B9AC2A Q28240412-E58F4C28-9FA1-47A6-82AB-7BC6619EBB3F Q28253008-7A9ACBB2-5BF3-47E4-9B73-A4C4CCFC065E Q28259868-692E9AEC-5B05-4F93-BBDB-1A716FB17C8B Q28265749-2A93672B-82D4-4914-B4F5-57D91911A9FD Q28297096-0822C122-0BED-410C-BE62-C02E72B983D2 Q28304022-6E4DF78E-91FD-4306-8C7D-12766DE78E1B Q28482901-D60DC564-10AA-48A7-864C-37EA20C7A623 Q28508610-210E7C4C-F2D4-4FDD-9BB4-3901B56811C4 Q28658055-8A651252-E369-4C2F-85D2-E4DC3E29412D Q28854278-ACF66A97-4BF4-40AD-830E-2D5FDAD3F02A Q30378182-EB1F4DE3-A438-41E3-B40F-F6F0A661DE74 Q30383732-9F17BA39-8880-4542-8998-475689366240 Q30539904-874EE1E1-8424-4D70-BFAA-C19DBC3CD313 Q30654383-E353AADA-FB41-4D54-8070-193380EB810E

P2860

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Item

http://www.wikidata.org/entity/Q34195822

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Calcium Upregulation by Percut ...... s with advanced heart failure.

@ast

Calcium Upregulation by Percut ...... s with advanced heart failure.

@en

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease

@nl

type

Item

label

Calcium Upregulation by Percut ...... s with advanced heart failure.

@ast

Calcium Upregulation by Percut ...... s with advanced heart failure.

@en

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease

@nl

prefLabel

Calcium Upregulation by Percut ...... s with advanced heart failure.

@ast

Calcium Upregulation by Percut ...... s with advanced heart failure.

@en

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease

@nl

P1476

Calcium Upregulation by Percut ...... s with advanced heart failure.

@en

P2093

Alex Yaroshinsky

http://www.w3.org/2001/XMLSchema#string

Barry Greenberg

http://www.w3.org/2001/XMLSchema#string

Brian Jaski

http://www.w3.org/2001/XMLSchema#string

Calcium Upregulation by Percut ...... Disease (CUPID) Investigators

http://www.w3.org/2001/XMLSchema#string

Daniel F Pauly

http://www.w3.org/2001/XMLSchema#string

Donna Mancini

http://www.w3.org/2001/XMLSchema#string

Howard Dittrich

http://www.w3.org/2001/XMLSchema#string

Krisztina M Zsebo

http://www.w3.org/2001/XMLSchema#string

Roger J Hajjar

http://www.w3.org/2001/XMLSchema#string

Thomas Cappola

http://www.w3.org/2001/XMLSchema#string

P2860

Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life.

Characterization of adeno-associated virus genomes isolated from human tissues.

Adeno-associated virus vectors in clinical trials.

Cardiac resynchronization in chronic heart failure.

Gene transfer in cardiac myocytes.

Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction

P304

304-313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.111.022889

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Mariell Jessup

P577

2011-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21709064

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

gene therapy

phase II clinical trial

P932

5843948

http://www.w3.org/2001/XMLSchema#string

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

about

P2860

P2860

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932